Clinical Trial Update: Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension [Phase 2]

View source ↗

Summary

Open-label extension results for Ecopipam in children and adolescents with Tourette Syndrome completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• Ecopipam (Ecopipam)

Snippet

Sponsor: Emalex Biosciences Inc. | Conditions: Tourette Syndrome in Children, Tourette Syndrome in Adolescence | Phase 2 | Status: COMPLETED | Results posted: 2023-12-01